Berenberg raised the firm’s price target on AstraZeneca to 15,000 GBp from 13,000 GBp and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca Completes Fusion Pharmaceuticals Acquisition
- AstraZeneca completes acquisition of Fusion Pharmaceuticals
- Regeneron price target raised to $1,200 from $1,185 at RBC Capital
- AstraZeneca reports Tagrisso plus chemo recommended for approval in EU
- AstraZeneca presents results from LAURA Phase III trial